Clinical trial reportJCO precision oncologyPublished
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2
Regional connection
Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, University of Pennsylvania. Affiliation source
- Institutions
- Thomas Jefferson University, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- JCO precision oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Mutation; Middle Aged; Urinary Bladder Neoplasms
- PubMed ID
- 38603650
- PubMed Central ID
- PMC11623915
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked